SANTA CLARA, Calif., Feb. 16, 2021 (GLOBE NEWSWIRE) -- Shockwave Medical, Inc. (NASDAQ: SWAV), a pioneer in the development of Intravascular Lithotripsy (IVL) to treat severely calcified ...
March 27, 2009 (Stockholm, Sweden) — Slowing the shockwave delivery rate from 100 to 70 shocks per minute reduced the cost of extracorporeal shockwave lithotripsy (SWL) by 50%, with no diminution in ...
The long-term effects of treating renal stones with extracorporeal shockwave lithotripsy are not fully understood. Potential problems include hypertension, decreased renal function and stone ...
Shockwave Medical's Intravascular Lithotripsy (IVL) system has received premarket approval from the US Food and Drug Administration (FDA) to treat severely calcified coronary artery disease, the ...
Please provide your email address to receive an email when new articles are posted on . Shockwave Medical announced its intravascular lithotripsy system received premarket approval from the FDA for ...
Approvals Cover Both Coronary and Peripheral IVL Catheters and Generators Manufactured by Shockwave About Shockwave Medical, Inc.Shockwave is focused on developing and commercializing products ...
Meta-analysis reveals a significantly increased risk only in male patients. Patients with stones smaller than 7 mm are more likely have a successful treatment than those with larger stones, ...
SANTA CLARA, Calif., April 13, 2020 (GLOBE NEWSWIRE) -- Shockwave Medical, Inc. (NASDAQ: SWAV), a pioneer in the development of Intravascular Lithotripsy (IVL) to treat complex calcified ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results